Compositions Comprising Glucagon Analogs And Methods Of Making And Using The Same

Patent No. EP2694095 (titled "Compositions Comprising Glucagon Analogs And Methods Of Making And Using The Same") was filed by Longevity Biotech on Apr 5, 2012. The application was issued on Mar 7, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ZEALAND PHARMADec 6, 2018MEWBURN ELLIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2694095

LONGEVITY BIOTECH
Application Number
EP12768072A
Filing Date
Apr 5, 2012
Status
Revoked
Jul 3, 2020
Publication Date
Mar 7, 2018